Selected Publications
- Klingenberg, M., Becker, J., Eberth, S., Kube, D., Wilting, J.: The NADPH oxidase inhibitor imipramine-blue in the treatment of Burkitt lymphoma. Mol. Cancer Ther. 13: 833-841 (2014)
- Exertier, P., Javerzat, S., Wang, B., Franco, M., Herbert, J., Platonova, N., Winandy, M., Nivelles, O., Ormenese, S., Godard, V., Becker, J., Bicknell, R., Cherifi, K., Wilting, J., Bikfalvi, A., Hagedorn, M.: Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5. Oncotarget 4: 2302-2316 (2013)
- Cader FZ, Vockerodt M, Bose S, Nagy E, Brundler MA, Kearns P, Murray PG. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1. Blood122: 4237-4245 (2013)
- Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. J Pathol 230: 399-409 (2013)
- Schrader A, Bentink S, Spang R, Lenze D, Hummel M, Kuo M, Arrand JR, Murray PG, Trümper L, Kube D, Vockerodt M. High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas. Int J Cancer 131: 348-61 (2012)
- Schniedermann, J., Rennecke, M., Buttler, K., Richter, G., Städtler, A.M., Norgall, S., Badar, M., Barleon, B., May, T., Wilting, J., Weich, H.A.: Mouse lung microvascular endothelial progenitor cells exhibit a high capacity for the formation of blood and lymphatic vessels. BMC Cell Biol. 11: 50 (2010)
- Albuquerque, R., Hayashi, T., Cho, W.G., Kleinman, M.E., Takeda, A., Baffi, J.Z., Yamada, K., Kaneko, H., Rich, M.G., Chappell, J., Wilting, J., Weich, H.A., Yamagami, S., Amano, S., Mizuki, N., Alexander, J.S., Peterson, M.L., Brekken, R.A., Hirashima, M., Capoor, S., Usui, T., Ambati, B.K., Ambati, J.: Alternatively spliced VEGF receptor-2 is an essential endogenous lymphangiogenesis inhibitor. Nat. Med. 15: 1023-1030 (2009)
- Volland, S., Kugler, W., Schweigerer, L., Wilting, J., Becker, J. Stanniocalcin 2 promotes invasion and is associated with progressed stages in neuroblastoma. Int. J. Cancer 125: 2049-2057 (2009)
- Valasek, P., Macharia, R., Neuhuber, W.L., Wilting, J., Becker, D.L., Patel, K.: Lymph heart in chick - somitic origin, development and embryonic oedema. Development 134: 4427-4436 (2007)
- Wilting, J., Buttler, K., Schulte, I., Papoutsi, M., Schweigerer, L., Männer J.: The proepicardium delivers hemangioblasts but not lymphangioblasts to the developing heart. Dev. Biol. 305: 451-459 (2007)
- Buttler, K., Kreysing, A., von Kaisenberg, C.S., Schweigerer, L., Gale, N., Papoutsi, M., Wilting, J.: Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Dev. Dyn. 235: 1554-1562 (2006)
- Wilting, J., Aref, Y., Huang, R., Tomarev, S.I., Schweigerer, L., Christ, B., Valasek, P., Papoutsi, M.: Dual origin of avian lymphatics. Dev. Biol. 292: 165-173 (2006)
- Becker J, Erdlenbruch B, Noskova I, Schramm A, Aumailley M, Schorderet DF, Schweigerer L (2006) Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res. 66: 5314-2
- Hecht, M., Tran, H., Papoutsi, M., Wilting, J., Schweigerer, L.: HGF / c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res. 64: 6109-6118 (2004)
- Wilting, J., Papoutsi, M., Christ, B., Nicolaides, K.H., von Kaisenberg, C.S., Borges, J., Stark, G.B., Alitalo, K., Tomarev, S.I., Niemeyer, C., Rössler, J.: The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased tissues. FASEB J. 16: 1271-1273 (2002)
- Oh S.-J., Jeltsch M.M., Birkenhäger, R., McCarthy, J.E.G., Weich, H.A., Christ, B., Alitalo K., Wilting,J.: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188: 96-109 (1997)
- Wilting, J., Christ, B., Weich, H.A.: The effects of growth factors on the day 13 chorioallantoic-membrane (CAM): A study of VEGF165 and PDGF-BB. Anat. Embryol. 186:251-257 (1992)